Hames Thomas, Leddington-Wright Sheila, Thake Charles Douglas, Price Mike
Health and Life Sciences, Coventry University, Coventry, UK.
BMJ Open Sport Exerc Med. 2022 Feb 28;8(1):e001248. doi: 10.1136/bmjsem-2021-001248. eCollection 2022.
To describe the characteristics of athletes with solid-organ transplants (TxA) attending the British and World Transplant Games.
220 TxA completed an online survey to explore transplant history, medications, training advice and support and limitations to training.
TxA were predominantly caucasian, male, kidney recipients in their mid-forties and approximately 11 years post-transplant. The majority of TxA took some form of medication (immunosuppressants 88%, steroids 47%, antihypertensives 47%, statins 28%, antiplatelets 26%, antibiotics/antivirals/antifungals 20%). Stem cell recipients were least likely to require medication. Post-transplant complications were experienced by 40% of TxA, with 53% of these being rejection. Although over half the participants (57%) initially received exercise or training advice post-transplant, only 34% of these received this from their consultants or immediate medical team. Only 1% had been specifically directed towards transplant sport. Half of the TxA (53%) perceived there were limitations preventing them from performing at their potential, 45% considered they did not recover from training as well as non-TxA while 29% felt they trained equally to non-Tx's. Only 6% considered medication impaired training. TxA competed for a range of reasons from social and health benefits to winning medals.
TxA compete at the British and World Transplant Games for a diverse range of reasons. Athletes manage a range of medications with a range of exercise and health experiences pre-transplant. TxA face a lack of both general and specific exercise training and recovery guidance. The individuality of each TxA's background should be considered and is likely reflected in their exercise capacity and goals.
描述参加英国和世界移植运动会的实体器官移植运动员(TxA)的特征。
220名TxA完成了一项在线调查,以探究移植病史、药物治疗、训练建议与支持以及训练的限制因素。
TxA主要为白种人、男性,是四十多岁的肾移植受者,移植后约11年。大多数TxA服用某种形式的药物(免疫抑制剂88%,类固醇47%,抗高血压药47%,他汀类药物28%,抗血小板药26%,抗生素/抗病毒药/抗真菌药20%)。干细胞移植受者最不需要药物治疗。40%的TxA经历过移植后并发症,其中53%为排斥反应。尽管超过一半的参与者(57%)在移植后最初接受过运动或训练建议,但其中只有34%是从他们的顾问或直接医疗团队那里获得的。只有1%曾被专门指导参加移植体育项目。一半的TxA(53%)认为存在限制因素妨碍他们发挥潜力,45%认为他们训练后的恢复情况不如非TxA,而29%觉得他们与非TxA训练程度相同。只有6%认为药物治疗会影响训练。TxA参赛的原因多种多样,从社交和健康益处到赢得奖牌。
TxA参加英国和世界移植运动会的原因多种多样。运动员在移植前会使用多种药物,并有着不同的运动和健康经历。TxA缺乏一般和特定的运动训练及恢复指导。应考虑每个TxA背景的独特性,这可能反映在他们的运动能力和目标上。